Check out Dr. David Lyerly’s appearance on C. diff Spores and More
Check out the edited video version below… Continue reading
- Home
- News
New research from the UVa School of Medicine links host immune response and Inflammatory Bowel Disease (IBD) to C. difficile severity
Read the entire article here: https://newsroom.uvahealth.com/2019/04/22/revealed-the-secret-superpower-that-makes-c-difficile-so-deadly… Continue reading
Dr. David Lyerly and James Boone appear as guests on C. diff Spores and More
On Tuesday, March 19, Dr. David Lyerly and James Boone joined Nancy Caralla, Executive Director of the C. diff Foundation, on the C. diff radio broadcast of Spores and More. Together, they discussed C. difficile research, clinical assays, autoimmune diseases including Inflammatory Bowel Disease, and C. difficile guidelines. Listen to the full episode here… Continue reading
Campylobacter culture fails to correctly detect Campylobacter in 30% of positive patient stool specimens compared to non-cultural methods
To read the full manuscript, click here… Continue reading
TECHLAB COO Robert Day elected to the board of Virginia Bio
TECHLAB Chief Operating Officer Robert Day has been elected to the board of Virginia Bio, the premier statewide non-profit association representing the life science industry in Virginia. Congratulations, Rob! Read the full article her… Continue reading
Dr. Bincy P. Abraham explains the benefits of fecal lactoferrin
Gastroenterology & Hepatology recently featured an interview with Dr. Bincy P. Abraham, Director of the Gastroenterology Fellowship Program at Houston Methodist. Dr. Abraham explains the benefits of fecal lactoferrin testing and how lactoferrin testing can help manage patients with IBD. Read the entire interview here… Continue reading
H. pylori webinar presented by Dr. David Lyerly
Join us for a webinar exploring H. pylori diagnosis and considerations for selecting the appropriate testing methodology. Click here to watch the archived version. … Continue reading
TECHLAB featured as a leader in infectious disease diagnostics
TECHLAB was recently featured on the website of the Valleys Innovation Council. Check out the article at https://www.valleysinnovation.org/techlab/ &nbs… Continue reading
TECHLAB participates in VT Corporate Research Center Media Day
On Tuesday, September 17, TECHLAB participated in the Virginia Tech Corporate Research Center’s Media Day event. We welcomed media representatives to TECHLAB to learn about our company history, the science behind our products, and our plans to grow in the future. CEO Dan Delaney and COO Rob Day explained that TECHLAB was founded in 1989 … Continue reading
PRESS RELEASE: TECHLAB® Receives FDA 510(k) Clearance to Market H. PYLORI QUIK CHEK™ and H. PYLORI CHEK™ Tests
BLACKSBURG, Va. – Aug. 21, 2018 – TECHLAB®, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, today announced that it received U.S. Food and Drug Administration (FDA) clearance for the H. PYLORI QUIK CHEK™ and the H. PYLORI CHEK™ tests. Both are designed to aid in the diagnosis of H. … Continue reading
